Cross-sectional assessments of participants' characteristics and loss to follow-up in the first Opioid Substitution Therapy Pilot Program in Kabul, Afghanistan

Harm Reduction Journal
Horacio Ruiseñor-EscuderoGilbert Burnham

Abstract

Kabul has over 12,000 people who inject drugs (PWID), most of them heroin users, and opioid substitution therapy has recently been introduced as an effective method to reduce opioid use. We aimed to evaluate a pilot Opioid Substitution Therapy Pilot Program (OSTPP) in Kabul, Afghanistan, particularly to (1) describe characteristics of the participants enrolled in the program and (2) identify factors associated with client retention in the OSTPP. Two cross-sectional surveys evaluated participants attending the OSTPP at baseline (n = 83) and 18 months after (n = 57). Questionnaires assessed socio-demographic, drug use behavior, and general and mental health factors. After 18 months, 57 participants remained in the OSTPP. Participants lost to follow-up were younger (p < 0.01) and married (p < 0.01) and had no family contact (p < 0.01). Participants at 18 months reported no criminal activity in the last month and only two (3.5 %) reported heroin use in the last month, constituting significant decreases from baseline. While preliminary results are promising, further evaluation is needed to determine the feasibility of implementing OSTPP in this setting and effectiveness in reducing injection risk behaviors in Afghanistan.

References

Dec 13, 2005·Journal of General Internal Medicine·Linda R GowingRobert L Ali
Apr 28, 2010·Journal of Public Health·Christian T BautistaPaul T Scott
Jul 24, 2010·Lancet·Steffanie A StrathdeeCatherine A Hankins
Nov 10, 2010·Journal of Acquired Immune Deficiency Syndromes : JAIDS·Chris BeyrerFrangiscos Sifakis
Jul 20, 2011·Journal of Addiction Medicine·Einat PelesMiriam Adelson
Jun 15, 2012·Journal of Addiction Medicine·Alexander Y WalleyDaniel P Alford
Jun 22, 2012·The International Journal on Drug Policy·Catherine S ToddCatherine Panter-Brick
Oct 6, 2012·BMJ : British Medical Journal·Georgie J MacArthurMatthew Hickman
Dec 15, 2012·Culture, Health & Sexuality·Fatou Maria DraméStefan Baral

❮ Previous
Next ❯

Citations

Apr 3, 2021·Substance Abuse Treatment, Prevention, and Policy·Ghazal MousavianAli Mirzazadeh

❮ Previous
Next ❯

Software Mentioned

STATA
MdM

Related Concepts

Related Feeds

Anxiety Disorders

Discover the latest research on anxiety disorders including agoraphobia, panic disorder, obsessive-compulsive disorder, and post-traumatic stress disorder here.

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Antipsychotic Drugs

Antipsychotic drugs are a class of medication primarily used to manage psychosis (including delusions, hallucinations, paranoia or disordered thought), principally in schizophrenia and bipolar disorder. Discover the latest research on antipsychotic drugs here

Alpha-Synuclein Aggregation (MDS)

Alpha-synucleins are small proteins that are believed to restrict the mobility of synpatic vesicles and inhibit neurotransmitter release. Aggregation of these proteins have been linked to several types of neurodegenerative diseases including dementia with Lewy bodies and Parkinson's disease. Here is the latest research on α-synuclein aggregation.